Brown,, D.C., Macfarlane,, C.E., McKenna,, W.J., Patton,, M.A., Dunger,, D.B., Savage,, M.O. and Kelnar,, C.J.H.. "Growth Hormone Therapy in Noonan's Syndrome: Non-Cardiomyopathic Congenital Heart Disease Does Not Adversely Affect Growth Improvement"
Journal of Pediatric Endocrinology and Metabolism, vol. 15, no. 6, 2002, pp. 851-852.
https://doi.org/10.1515/JPEM.2002.15.6.851Brown,, D., Macfarlane,, C., McKenna,, W., Patton,, M., Dunger,, D., Savage,, M. & Kelnar,, C. (2002). Growth Hormone Therapy in Noonan's Syndrome: Non-Cardiomyopathic Congenital Heart Disease Does Not Adversely Affect Growth Improvement.
Journal of Pediatric Endocrinology and Metabolism,
15(6), 851-852.
https://doi.org/10.1515/JPEM.2002.15.6.851Brown,, D., Macfarlane,, C., McKenna,, W., Patton,, M., Dunger,, D., Savage,, M. and Kelnar,, C. (2002) Growth Hormone Therapy in Noonan's Syndrome: Non-Cardiomyopathic Congenital Heart Disease Does Not Adversely Affect Growth Improvement. Journal of Pediatric Endocrinology and Metabolism, Vol. 15 (Issue 6), pp. 851-852.
https://doi.org/10.1515/JPEM.2002.15.6.851Brown,, D.C., Macfarlane,, C.E., McKenna,, W.J., Patton,, M.A., Dunger,, D.B., Savage,, M.O. and Kelnar,, C.J.H.. "Growth Hormone Therapy in Noonan's Syndrome: Non-Cardiomyopathic Congenital Heart Disease Does Not Adversely Affect Growth Improvement"
Journal of Pediatric Endocrinology and Metabolism 15, no. 6 (2002): 851-852.
https://doi.org/10.1515/JPEM.2002.15.6.851Brown, D, Macfarlane, C, McKenna, W, Patton, M, Dunger, D, Savage, M, Kelnar, C. Growth Hormone Therapy in Noonan's Syndrome: Non-Cardiomyopathic Congenital Heart Disease Does Not Adversely Affect Growth Improvement.
Journal of Pediatric Endocrinology and Metabolism. 2002;15(6): 851-852.
https://doi.org/10.1515/JPEM.2002.15.6.851Copied to clipboard
